Cargando…
The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapy
BACKGROUND: Tyrosine-kinase inhibitor (TKI) targeting angiogenesis improves the prognosis of patients with metastatic renal cell carcinoma (RCC), but its effect is temporary. In order to understand the mechanism by which RCC acquires resistance to TKI, we investigated the change of glucose accumulat...
Autores principales: | Nakaigawa, Noboru, Kondo, Keiichi, Ueno, Daiki, Namura, Kazuhiro, Makiyama, Kazuhide, Kobayashi, Kazuki, Shioi, Koichi, Ikeda, Ichiro, Kishida, Takeshi, Kaneta, Tomohiro, Minamimoto, Ryogo, Tateishi, Ukihide, Inoue, Tomio, Yao, Masahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223335/ https://www.ncbi.nlm.nih.gov/pubmed/28068944 http://dx.doi.org/10.1186/s12885-016-3044-0 |
Ejemplares similares
-
FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma
por: Nakaigawa, Noboru, et al.
Publicado: (2016) -
The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ
por: Kakizoe, Manabu, et al.
Publicado: (2014) -
Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course
por: Ueno, Daiki, et al.
Publicado: (2012) -
Impact of maximum Standardized Uptake Value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography ((18)F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report
por: Namura, Kazuhiro, et al.
Publicado: (2010) -
Series of myocardial FDG uptake requiring considerations of myocardial abnormalities in FDG-PET/CT
por: Minamimoto, Ryogo
Publicado: (2021)